<code id='E48D416226'></code><style id='E48D416226'></style>
    • <acronym id='E48D416226'></acronym>
      <center id='E48D416226'><center id='E48D416226'><tfoot id='E48D416226'></tfoot></center><abbr id='E48D416226'><dir id='E48D416226'><tfoot id='E48D416226'></tfoot><noframes id='E48D416226'>

    • <optgroup id='E48D416226'><strike id='E48D416226'><sup id='E48D416226'></sup></strike><code id='E48D416226'></code></optgroup>
        1. <b id='E48D416226'><label id='E48D416226'><select id='E48D416226'><dt id='E48D416226'><span id='E48D416226'></span></dt></select></label></b><u id='E48D416226'></u>
          <i id='E48D416226'><strike id='E48D416226'><tt id='E48D416226'><pre id='E48D416226'></pre></tt></strike></i>

          hotspot

          hotspot

          author:fashion    Page View:2442
          Adobe

          Pharmacists increasingly are being asked to make drugs in bulk for hospitals that are in short supply, and they’re even beginning to make chemotherapies. But some in the industry worry about the unintended consequences of overreliance.

          Hospitals’ reliance on pharmacist-made drugs, a practice called compounding, has risen in step with worsening drug shortages.

          advertisement

          When the American Society of Health-System Pharmacists surveyed its members this past summer, 59% said they increased purchases from compounders because of drug shortages.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          leisure time

          Medicare proposal to cover medical devices draws a mixed reaction
          Medicare proposal to cover medical devices draws a mixed reaction

          AdobeThemedicaldeviceindustryissplitonwhetheraproposednewMedicarereimbursementpathwaywilldoanythingt

          read more
          Medicare drug price negotiation’s day in court
          Medicare drug price negotiation’s day in court

          AdobeYou’rereadingthewebeditionofD.C.Diagnosis,STAT’stwice-weeklynewsletteraboutthepoliticsandpolicy

          read more
          FDA approval of Sarepta Duchenne genetic therapy gives me hope
          FDA approval of Sarepta Duchenne genetic therapy gives me hope

          Duchennemusculardystrophyhistopathology.Dr.EdwinP.Ewing,Jr./CDCWhenIwasdiagnosedwithDuchennemuscular

          read more

          Commercial surrogacy can be ethical, despite pope’s claims

          AdobeOverthepastfewyears,IhavewatchedawonderfulyoungboyI’llcallChadgrowupsmartandfulloflife.Hisparen